TetraLogic Pharmaceuticals Corporation
TetraLogic Pharmaceuticals Corporation (TLOG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TLOG · as of Jun 9, 2026
Key Statistics
Explore TetraLogic Pharmaceuticals Corporation Data
tlog stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
tlog competitorsTLOG
AMPE
ARNI
BTTX
BXRXQ
CALAStock Performance
Full HistoryAbout TetraLogic Pharmaceuticals Corporation
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious d…
what is tetralogic pharmaceuticals corporation · tlog stock overview · tetralogic pharmaceuticals corporation company profile · who is tetralogic pharmaceuticals corporation ceo · tlog OTC · tetralogic pharmaceuticals corporation headquarters · tetralogic pharmaceuticals corporation business segments
About Stock Overview & Key Data
TetraLogic Pharmaceuticals Corporation (TLOG) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 12, 2013. As of the latest trading session, TLOG stock price is $0.00, with a market capitalization of $979. The stock has returned -60.00% over the past 12 months and -60.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for TetraLogic Pharmaceuticals Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2015, TetraLogic Pharmaceuticals Corporation reported revenue of — and net income of -$56.1M. For detailed data — including TetraLogic Pharmaceuticals Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, TetraLogic Pharmaceuticals Corporation (TLOG) stock price is $0.00. The stock is traded on OTC under the ticker symbol TLOG. The 52-week range is $0.00 – $0.00.